Leitlinie „Behandlung der Akne“ - AWMF
Leitlinie „Behandlung der Akne“ - AWMF
Leitlinie „Behandlung der Akne“ - AWMF
Sie wollen auch ein ePaper? Erhöhen Sie die Reichweite Ihrer Titel.
YUMPU macht aus Druck-PDFs automatisch weboptimierte ePaper, die Google liebt.
013/017 - Behandlung <strong>der</strong> Akne aktueller Stand: 02/2010<br />
korrigierte Fassung: 10/2011<br />
470. Worret WI, Fluhr JW. [Acne therapy with topical benzoyl peroxide, antibiotics and<br />
azelaic acid]. J Dtsch Dermatol Ges. 2006; 4: 293-300.<br />
471. Kretschmar R, Leuschner F. Investigation on the toxicity of tretinoin administered<br />
systemically to animals. Acta Derm Venereol Suppl (Stockh). 1975; 74: 25-8.<br />
472. van Hoogdalem EJ. Trans<strong>der</strong>mal absorption of topical anti-acne agents in man; review<br />
of clinical pharmacokinetic data. J Eur Acad Dermatol Venereol. 1998; 11 Suppl 1:<br />
S13-9; discussion S28-9.<br />
473. Nau H. Embryotoxicity and teratogenicity of topical retinoic acid. Skin Pharmacol.<br />
1993; 6 Suppl 1: 35-44.<br />
474. Krautheim A, Gollnick H. Trans<strong>der</strong>mal penetration of topical drugs used in the<br />
treatment of acne. Clin Pharmacokinet. 2003; 42: 1287-304.<br />
475. Duran B, Gursoy S, Cetin M, Demirkoprulu N, Demirel Y, Gurelik B. The oral<br />
toxicity of resorcinol during pregnancy: a case report. J Toxicol Clin Toxicol. 2004;<br />
42: 663-6.<br />
476. Thiboutot DM. Overview of acne and its treatment. Cutis. 2008; 81: 3-7.<br />
477. Hale EK, Pomeranz MK. Dermatologic agents during pregnancy and lactation: an<br />
update and clinical review. Int J Dermatol. 2002; 41: 197-203.<br />
478. Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med. 1998; 338: 1128-37.<br />
479. Morsches B, Holzmann H. [Studies on the percutaneous absorption of benzoyl<br />
peroxide (author's transl)]. Arzneimittelforschung. 1982; 32: 298-300.<br />
480. Nacht S, Yeung D, Beasley JN, Jr., Anjo MD, Maibach HI. Benzoyl peroxide:<br />
percutaneous penetration and metabolic disposition. J Am Acad Dermatol. 1981; 4:<br />
31-7.<br />
481. Cunliffe WJ, Gollnick HPF, Orfanos CE. Akne. Hippokrates Verlag, Stuttgart, 1993.<br />
ISBN: 1841844047<br />
482. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, Shalita AR,<br />
Thiboutot D. Management of acne: a report from a Global Alliance to Improve<br />
Outcomes in Acne. J Am Acad Dermatol. 2003; 49 Suppl 1: S1-37.<br />
483. Tauber U, Weiss C, Matthes H. Percutaneous absorption of azelaic acid in humans.<br />
Exp Dermatol. 1992; 1: 176-9.<br />
484. Cooper WO, Griffin MR, Arbogast P, Hickson GB, Gautam S, Ray WA. Very early<br />
exposure to erythromycin and infantile hypertrophic pyloric stenosis. Arch Pediatr<br />
Adolesc Med. 2002; 156: 647-50.<br />
485. Weinstein AJ, Gibbs RS, Gallagher M. Placental transfer of clindamycin and<br />
gentamicin in term pregnancy. Am J Obstet Gynecol. 1976; 124: 688-91.<br />
486. McCormack WM, George H, Donner A, Kodgis LF, Alpert S, Lowe EW, Kass EH.<br />
Hepatotoxicity of erythromycin estolate during pregnancy. Antimicrob Agents<br />
Chemother. 1977; 12: 630-5.<br />
487. Gallagher JC, Ismail MA, Aladjem S. Reduced urinary estriol levels with<br />
erythromycin therapy. Obstet Gynecol. 1980; 56: 381-2.<br />
488. Dreno B, Blouin E. [Acne, pregnant women and zinc salts: a literature review]. Ann<br />
Dermatol Venereol. 2008; 135: 27-33.<br />
Seite 135 von 136